22.20Open22.20Pre Close0 Volume17 Open Interest130.00Strike Price0.00Turnover96.84%IV-3.24%PremiumMay 16, 2025Expiry Date27.29Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9751Delta0.0037Gamma5.72Leverage Ratio-0.1104Theta0.0134Rho5.58Eff Leverage0.0095Vega
Natera Stock Discussion
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
How Natera's New Patent Could Reshape Cancer Detection Technology
Natera Scores Critical Medicare Coverage Win for Lung Cancer Test - What This Means for Patients and Investors
Major Clinical Guidelines Update: Natera's Cancer Test Shows 20x Better Risk Detection
-Billionaire investor Stanley Druckenmiller told Bloomberg on Wednesday that selling all his Nvidia stock this year was a “big mistake.”
-Nvidia was Druckenmiller's top holding a year ago, but he sold it after the stock tripled in 2023.
-The shares are up another 174% this year, and Druckenmiller has missed much of the continuing rally.
Stanley Druckenmiller is an American billionair...
No comment yet